Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02319850 · ClinicalTrials.gov registry record

Muscle Ultrasound for Sarcopenia Leading to Early Detection

A clinical trial, sponsored by George Washington University.

Completed
Registry status
34
Enrollment target

NCT02319850: Completed study, sponsored by George Washington University.

NCT02319850 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02319850 has completed, sponsored by George Washington University.

COMPLETED
Registry status
34 participants
Enrollment target

Study Summary

Sarcopenia is an age-related loss of muscle mass that may affect over 25% of individuals over the age of 60 and results in a 3 to 4 times increased likelihood of developing a disability. Despite these observations, sarcopenia is rarely subject to a systematic screening process as a part of customary geriatric care. Furthermore, when lean body mass (LBM) is measured via dual energy X-ray absorptiometry (DXA) in older adults, it is typically within a reactive, hospital-based, model of healthcare where muscle wasting is only assessed after a loss of functional independence. The investigators propose an affordable, portable screening method with ultrasound imaging to be performed in primary care settings. The investigators long term goal is to identify individuals at risk, and intervene with treatments that may prevent the onset of debilitating loss of muscle function in the elderly.

Primary Outcome

US estimates of aggregate regional LBM (muscle thickness, cm), will be assessed using B-mode diagnostic US with a 13-6 megahertz linear array transducer for morphology measures at 5 axial and appendicular sites.

Interventions

  • RADIATION DXA scanning

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2014-02
Est. Completion 2015-12
George Washington University

133 total trials

What the finished NCT02319850 record still lists

NCT02319850 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which DXA scanning is the first listed.

NCT02319850 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02319850 about?

NCT02319850 is a clinical study titled "Muscle Ultrasound for Sarcopenia Leading to Early Detection". Sarcopenia is an age-related loss of muscle mass that may affect over 25% of individuals over the age of 60 and results in a 3 to 4 times increased likelihood of developing a disability. Despite these observations, sarcopenia is rarely subject to a systematic screening process as a part of customary...

What is the current status of trial NCT02319850?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2014-02. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02319850?

The interventions under investigation include: DXA scanning (RADIATION).

Who is sponsoring clinical trial NCT02319850?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02319850, the US trial registry maintained by the National Library of Medicine. NCT02319850 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.